Mizuho Securities Reiterates Buy Following Ventas' (VTR) 35% YTD Stock Increase PT to $84
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Ventas Reports 2016 Second Quarter Results
July 29, 2016 6:53 AM EDTContinued Strong Track Record of Earnings Growth Enhanced Companys Credit Profile Through Excellent Capital Markets Execution Announced $1.5 Billion Acquisition of Wexford Life Science and Medical Real Estate
CHICAGO--(BUSINESS WIRE)-- Ventas, Inc. (NYSE: VTR) (Ventas or the Company) today announced strong earnings on a healthy balance sheet for the second quarter of 2016, driven by excellent performance from the Companys high-quality healthcare and senior living properties and accretive acquisitions:
Income from continuing operations per diluted common share for... More